Table 3.
Patient | Gender | Age | Underlying disease | Drug | Dur treat (M) | DD (mg/d) | RD | Cause of death |
---|---|---|---|---|---|---|---|---|
25 | F | 59 | RA | CQ | 10 | 250 | No | Cardiac insufficiency and broncopneumonia |
29 | M | 68 | RA | CQ | 31 | 250 | No | Myocardial infarction |
31 | M | 77 | Psoriatic arthritis | HQC | 74 | 400 | No | Sepsis |
32 | F | 78 | RA | CQ | 28 | 250 | No | Heart failure |
44 | F | 88 | RA | HQC | 60 | 600 | Y | Obstructive airway disease |
45 | F | 56 | SLE/SS/autoimmune hepatitis | HQC | 6 | 400 | Y | Gallstones and sepsis |
46 | F | 64 | PSS/ILD | HQC | 48 | 400 | Y | Pulmonary fibrosis/Nocardia/Aspergillus |
CQ, chloroquine; HQC, hydroxichloroquine; Dur treat (M), duration of treatment; DD, daily dose; RD, respiratory distress; M, months; m/d, milligrams per day; Y, yes